Charles L. Sawyers, MD

Publications

302

4 grants

MPI
Administrative Core
NCI · 2024–2029 · via NIH RePORTER
P01CA275746-03
MPI
Project 3: Therapeutic Targeting of Lineage Plasticity in Castration-Resistant Prostate Cancer
NCI · 2001–2027 · via NIH RePORTER
P50CA092629-25
MPI
Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response
NCI · 2022–2027 · via NIH RePORTER
P01CA265768-05
MPI
Functional Evaluation and Interpretation of DNA Damage Repair Variants in Prostate Cancer
NCI · 2019–2026 · via NIH RePORTER
P01CA228696-05

Completed grants (11)

PI
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
NCI · 2015–2025 · via NIH RePORTER
R01CA193837-10
PI
Understanding Resistance to Next Generation Antiandrogens
NCI · 2012–2023 · via NIH RePORTER
R01CA155169-10
PI
Molecular Biology in Clinical Oncology Workshop
NCI · 1992–2023 · via NIH RePORTER
R25CA057732-28S1
MPI
Project 1: Resistance caused by AR pathway reactivation
NCI · 2017–2023 · via NIH RePORTER
U54CA224079-04
PI
Translational Research in Oncology Training Program
NCI · 2011–2022 · via NIH RePORTER
T32CA160001-10
MPI
AKT-independent Pathways of Phosphoinositide 3-kinase dependent transformation
NCI · 2006–2013 · via NIH RePORTER
P01CA089021-10
PI
Mouse Models for Human Prostate Cancer
NCI · 1999–2010 · via NIH RePORTER
U01CA084128-10
PI
PHASE I TRIAL OF 17-N-ALLYLAMINO-17-DEMETHOXY GELDANAMYCIN (17-AAG, NSC #330
NCRR · 2003–2005 · via NIH RePORTER
M01RR000865-32
PI
REGULATION OF THE PTEN GENE IN PROSTATE CANCER
NCI · 2000–2005 · via NIH RePORTER
R01CA087079-02
PI
REGULATION OF THE PTEN TUMOR SUPPRESSOR GENE IN PROSTATE CANCER
NCI · 1997–2003 · via NIH RePORTER
P01CA032737-18A2
PI
STEM CELL GENES IN PROSTATE GROWTH AND DIFFERENTIATION
NIDDK · 1998–2003 · via NIH RePORTER
R01DK052673-04